"10.1371_journal.pone.0043044","none","2012-10-09T00:00:00Z","Ulrich Deuschle; Julia Schüler; Andreas Schulz; Thomas Schlüter; Olaf Kinzel; Ulrich Abel; Claus Kremoser","Department of Research, Phenex Pharmaceuticals AG, Heidelberg, Germany; Department of In Vivo Tumor Biology, Oncotest GmbH, Freiburg, Germany; Department of Medicinal Chemistry, Merz Pharmaceuticals GmbH, Frankfurt, Germany","Conceived and designed the experiments: UD JS AS TS. Performed the experiments: UD AS TS. Analyzed the data: UD JS AS TS. Contributed reagents/materials/analysis tools: UD AS UA OK. Wrote the paper: UD CK.","UA is a full-time employee of Merz Pharmaceuticals GmbH, JS is a full-time employee of Oncotest GmbH and the rest of the authors are full-time employees of Phenex Pharmaceuticals AG. UD and CK are co-founders of Phenex Pharmaceuticals AG and UD, AS and CK do own shares of Phenex Pharmaceuticals AG. Kremoser C, Abel U, Steeneck C, Kinzel O (2011) Patent Application WO2011/020615 Novel FXR (NR1H4) binding and activity modulating compounds. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","10","Ulrich Deuschle","UD",7,TRUE,4,3,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
